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The ontogenic source of definitive hematopoietic system has been identified in non-mammalian vertebrates such as birds and amphibians by
orthotopic embryo grafting, but remains unclear for mammals because of technical difficulties. Here, we successfully generated mouse chimeras
by grafting yolk sac (YS) on YS of the host embryos before establishing circulation between YS and embryo proper and cultured the whole
embryo for 66 h. Donor YS were isolated from C57BL/6 Ly-5.1 and EGFP-transgenic mouse embryos, and recipient embryos from C57BL/6
Ly-5.2 mouse. Almost one-half of the grafts in YS–YS chimeras survived and had obvious blood flow; graft-derived cells comprised 12.7±0.9% of
the blood cells in the circulation. These graft-derived blood cells consisted mainly of erythroid cells, some myeloid cells and a few blastic cells. In
addition, CD19+ B cells were generated from the graft-derived cells isolated from aorta–gonad–mesonephros (AGM) regions of the YS–YS
chimeras; however, the frequency of the YS-derived B cell was low (1.0±0.6%) when co-cultured with OP9 stromal cells. These results demonstrate
that B cell potential exists in YS before the circulation. Although the major source for B cell is intra-embryonic AGM region, YS may contribute to
definitive lymphopoiesis in vivo in mice.
© 2006 Elsevier Inc. All rights reserved.Keywords: Hematopoiesis; B cell; yolk sac; AGM regionAbbreviations: YS, yolk sac; AGM, aorta–gonad–mesonephros; dpc, days
post coitum; HSCs, hematopoietic stem cells; P-Sp, para-aortic splanchno-
pleure; SCF, stem cell factor; IL, interleukin.
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During mouse embryogenesis, hematopoiesis begins in yolk
sac (YS) blood islands at 7.5 days post coitum (dpc), shifting to
the fetal liver at midgestation and then to the spleen and bone
marrow shortly before birth. Primitive hematopoiesis prior to
the formation of fetal liver is transient, whereas definitive
hematopoiesis including lymphopoiesis continues throughout
life. Because hematopoiesis is first detected in the YS of
developing mouse embryos, it is believed that YS is the only
site generating pluripotent hematopoietic stem cells (HSCs) that
supposedly migrate to the fetal liver to give rise to definitive
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myeloid progenitors are present in the YS before 8 dpc supports
this hypothesis (Moore and Metcalf, 1970; Palis et al., 1999).
However, recent studies have challenged this hypothesis,
indicating that there exists a hematopoietic tissue for definitive
hematopoiesis within the embryo proper at the pre-liver stage.
The B cell progenitors that can be cloned on the ST2 stromal
cell layer are first detected in the embryo rather than the YS at
9.5 dpc. Once developed in the embryo, B cells immediately
enter the blood circulation and reside in the developing fetal liver
and in the YS at 10 dpc (Ogawa et al., 1988). Lymphohema-
topoietic activity is detected in the para-aortic splanchnopleure
(P-Sp) of the embryo at 7.5 dpc before the establishment of
circulation between the YS and embryo proper (Cumano et al.,
1996). In addition, multipotent HSCs capable of long-term
reconstitution in Rag2γc-deficient mice are present in the P-Sp
at 8.0 dpc as shown in organ culture assays (Cumano et al.,
2001). Furthermore, HSCs with reconstituting ability in adult
recipients are first found in the aorta–gonad–mesonephros
(AGM) region originating from the P-Sp and are autonomously
generated at 10 dpc in organ culture (Muller et al., 1994;
Medvinsky and Dzierzak, 1996). These studies indicate that
definitive hematopoiesis emerges from the P-Sp/AGM region
within the embryo, independent of YS.
The finding that definitive hematopoiesis emerges from the
P-Sp/AGM region is compatible with hematopoietic cell
development in birds and amphibians, which has been analyzed
by orthotopic embryo grafting experiments. In avian embryos,
embryo–YS grafting experiments have provided evidence that
definitive hematopoiesis arises only from an intra-embryonic
site around the dorsal aorta, whereas YS-derived cells generate a
transient wave of primitive hematopoiesis (Dieterlen-Lievre,
1975). In addition, similar findings were obtained in amphibians
from grafting experiments (Dieterlen-Lievre and Le Douarin,
1993). Furthermore, the ventral blood islands and the dorsal
lateral plate differentially give rise to primitive erythrocytes and
adult hematopoietic cells, respectively (Turpen et al., 1981).
In contrast, several reports have indicated that YS contains
cells that contribute to definitive hematopoiesis. When injected
in the YS cavity, the YS mononuclear cells, at 8.0 to 11.0 dpc,
contribute to lymphohematopoiesis (Weissman et al., 1977).
The YS at 8.0 and 8.5 dpc contains progenitors that can give
rise, in vivo and in vitro, to mature T and B-lymphocytes
(Palacios and Imhof, 1993). CD34+ cells isolated from the YS
as well as the P-Sp/AGM region at 9.0 dpc can reconstitute
neonatal recipients (Yoder et al., 1997). Endothelial cells sorted
out from the YS and the caudal half of mouse embryos at
9.5 dpc generate blood cells including lymphocytes (Nishikawa
et al., 1998; Fraser et al., 2002). These findings suggest that
definitive hematopoiesis has two origins in mice: the YS and
the intra-embryonic P-Sp/AGM region prior to the liver
hematopoiesis.
The microenvironment is important for the development of
embryonic hematopoietic progenitors and HSCs because the
hematopoietic site shifts as the embryo ages. AGM-region-
derived cell lines capable of supporting mouse and human
hematopoiesis have been reported (Ohneda et al., 1998; Xu etal., 1998). We have shown that cells isolated from the YS and
P-Sp contribute to definitive hematopoiesis when co-cultured
with a stromal cell line derived from the mouse AGM region at
10.5 dpc (Matsuoka et al., 2001). It is thus hypothesized that the
progenitors of definitive hematopoietic cells generated in the YS
(i.e., outside of the P-Sp) migrate to the P-Sp/AGM region
through the bloodstream and acquire the potential to produce
definitive hematopoietic cells. This may explain the controversy
on the origin of murine definitive hematopoiesis.
To address this issue, it is necessary to generate chimeric
mouse embryos before the establishment of circulation because
cell migration through the circulation hinders investigation of
the autonomous potential of hematopoietic tissues in the mouse
embryo. However, such experiments are difficult in mammals,
especially in mice, because the thick uterine membrane prevents
the micromanipulation of embryos. To overcome this problem,
we have used the whole embryo culture system, in which mouse
embryos are allowed to develop appropriately for 24 to 72 h
(Osumi-Yamashita et al., 1997; Sugiyama et al., 2003). We then
engrafted 8.25 dpc mouse YS on host embryos at the same stage
to generate YS–YS chimeric embryos and incubated these in
the whole embryo culture system. After being cultured,
embryos with vascularized grafts were examined to determine
whether cells derived from the donor YS in the AGM region
could differentiate into the B cell lineage.
Methods
Mice
EGFP-transgenic mice in which all cells express fluorescent EGFP were
kindly provided by Dr. M Okabe (Osaka University, Osaka, Japan) (Okabe et al.,
1997). C57BL/6 Ly-5.1 mice whose leukocytes express CD45.1 antigen were
kindly provided by Dr. K Ikuta (Kyoto University, Kyoto, Japan). C57BL/6 Ly-
5.2 mice were purchased from CLEA Japan, Inc. (Tokyo, Japan). These mice
were bred and maintained in a specific pathogen-free microisolator environ-
ment. The midday when the plug was detected in mated female mice was
considered to be 0.5 dpc.
Isolation of embryos and making YS–YS chimeras
Pregnant females at 8.25 dpc were sacrificed by cervical dislocation, and
embryos were dissected out from the uterus. Embryos at 1 to 5 somite pair
stage were chosen for donors in the engraftment. The EGFP-transgenic mice
and the C57BL/6 Ly-5.1 mice were used as the donors for the graft YS, and the
C57BL/6 Ly-5.2 mice as the hosts. A small hole was made in the YS of the
host embryos and patched with the whole donor YS tissue to make YS–YS
chimeras.
Whole mouse embryo culture
Whole mouse embryo culture was carried out in the system purchased from
Ikemoto Scientific Technology, Tokyo, Japan as previously described (Osumi-
Yamashita et al., 1997; Sugiyama et al., 2003). After making YS–YS chimeras,
they were transferred immediately into culture bottles containing 100% rat
serum supplemented with 2 mg/ml of glucose. The culture bottles were attached
to rotator drum and rotated at 20 rpm and 37°C while being continuously
supplied with a gas mixture (5% O2 and 5% CO2 balanced with N2 for the first
18 h, 20% O2 and 5% CO2 balanced with N2 for the second 12 h and
subsequently with 60% O2 and 5% CO2 balanced with N2). Gas control was
manually adjusted every 6 h approximately to keep their heart beat rate from 120
to 150/min. The embryos were cultured for 66 h.
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After the 66 h whole mouse embryo culture, YS–YS chimeras were
separated into the YS, AGM region and the rest part of embryos with forceps in
phosphate-buffered saline (PBS). Each tissue was incubated with 3 mg/ml
dispasell solution (Roche, Mannheim, Germany) for 30 min at 37°C and washed
once with alpha-minimal essential medium (Flow Laboratories, Rockville, MD)
containing 20% fetal calf serum (Hyclone Laboratories, Logan, UT). Cells were
dissociated by gentle pipetting, and large clumps were removed by nylon mesh.
Blood samples of the YS–YS chimeras were obtained by cutting YS arteries
with forceps.
Culture with OP9 stromal cells
For generating B cells, dissociated cells were cultured with OP9 stromal
cells in alpha-minimal essential medium (Flow Laboratories, Rockville, MD)
containing 10% fetal calf serum (Hyclone Laboratories, Logan, UT), 5×10−5 M
2-mercaptoethanol (Eastman Organic Chemicals, Rochester, NY), 50 ng/ml
mouse SCF (a gift from Kirin Co. Ltd, Tokyo, Japan) and 200 U/ml mouse IL-7
(a gift from Toray Co. Ltd, Tokyo, Japan). After 12 to 14 days of culture, cells
were harvested by vigorous pipetting and analyzed by flow cytometry.
Flow cytometry
Cells were analyzed by flow cytometry as described previously (Sugiyama
et al., 2005). Briefly, fluorescein isothiocyanate-conjugated and biotin-
conjugated anti-CD45.1, biotin-conjugated anti-CD19 and phycoerythrin
(PE)-conjugated anti-B220 monoclonal antibodies (mAb) were purchased
from Pharmingen (San Diego, CA). For surface staining, cell suspensions were
incubated on ice in the presence of various mixtures of labeled mAb. When
biotin-conjugated mAb were used, they were washed and incubated with
streptavidin (SA) conjugated to PE (Pharmingen, San Diego, CA) or PE-5-
succinimidylester (DAKO, Kyoto, Japan). Stained cells were analyzed by
FACScan (Becton Dickinson, San Jose, CA). EGFP+ cells in the blood of YS–
YS chimeras were sorted by FACSVantage (Becton Dickinson, Mountain View,
CA). The sorted cells were cytocentrifuged on Cytospin 2 (Shandon, Pittsburgh,
PA) and stained with May–Grünwald–Giemsa (Muto Chemica, Tokyo, Japan).Table 1
Summary of grafts of donor yolk sac containing blood islands to various regions
of host yolk sac
Graft position The percentage of developed conceptuses
No graft 62.0% (67/108)
Anterior 0% (0/10)
Posterior 10% (1/10)
Lateral 59.3% (147/248)
Embryos engrafted with the graft yolk sac to various positions (anterior,
posterior or lateral) were cultured for 66 h from 8.25 days post coitum and
evaluated according to the criteria (i.e., completed turning, neural tube closed
and obvious blood flow in the YS and body accompanying the heart beat).Results
Development of chimeric embryos
Before generating YS–YS chimeric embryos, we tested
whether the whole embryo culture system could support the
development of mouse embryos from 8.25 dpc, before the
establishment of circulation between the YS and the embryo
proper, to 11.0 dpc-equivalent, when the AGM region was
already formed. C57BL/6 Ly-5.2 mouse embryos at 8.25 dpc,
with somite pair number less than 5, were incubated in the
whole embryo culture system for 66 h. A total of 67 of 108
embryos (62.0%) survived with a heart beat and satisfied our
criteria for proper development (i.e., completed turning, neural
tube closed and obvious blood flow in the YS and body
accompanying the heart beat), which were devised referring to
the Brown–Fabro scoring system (Table 1) (Brown and Fabro,
1981). One somite pair develops approximately every 2 h.
However, the tip of the tail, which should contain 38 somite
pairs after 66 h, gradually degenerated during culturing, and it
was difficult to count the exact number of somite pairs.
However, the number of somite pairs in the cultured embryos
that satisfied the criteria was greater than 30, which suggests
that these embryos were at least 10.5 dpc-equivalent.The whole embryo culture of YS–YS chimeras started at
8.25 dpc. The donor embryos for the graft were divided into
embryo proper and YS containing whole blood islands (Fig.
1A). A small hole was made on the YS (indicated by the
arrowhead in Fig. 1B) and was patched with the graft YS to
make a YS–YS chimera (Fig. 1C). After 66 h in whole embryo
culture, the development of the chimeric embryos varied
depending on the position of the hole on the host YS. When
the graft YS were transplanted to the anterior or posterior region
of the host YS, no or few embryos developed adequately (Table
1). Most of them could not complete turning or closing their
neural tubes. However, 147 of 248 embryos (59.3%) engrafted
with the donor YS to the lateral region of the YS developed
properly according to the criteria (Figs. 1D and E). Therefore,
we transplanted the donor YS on the lateral region of the host
YS in the present study.
Migration of donor YS-derived cells into the host embryo
through vessel connection
The hearts of the cultured embryos continued beating for
several minutes after the embryos were transferred from the
culture bottles. In 71.4% (105/147) of the developed YS–YS
chimeric embryos that satisfied our criteria, we observed
vigorous blood flow in the donor YS accompanying the heart
beat of the host embryo. This reflects the presence of a blood
vessel connection between the donor YS and the host. The
vascularized graft appeared as a projection from the host YS
(indicated by the arrowheads in Figs. 1D–F). To confirm the
establishment of a blood vessel connection between the graft
YS and the host, we used the YS of F1 embryos of EGFP-
transgenic mice as donors and observed EGFP illumination
under the fluorescence microscope. After 66 h of culture,
EGFP+ blood cells derived from the donor YS were dispersed
throughout the host body (Figs. 2A and B), including the AGM
region (Figs. 2C and D), in 71.4% (105/147) of the developed
YS–YS chimeric embryos. The EGFP+ blood cells were
moving through the circulation in accordance with the heart
beat of the host embryos.
We then performed flow cytometric analysis of blood cells
drained from the incised YS arteries of the cultured YS–YS
chimeras engrafted with YS from EGFP+ embryos. As shown in
Fig. 3A, 12.7±0.9% (n=4) of the blood cells were EGFP+ cells
derived from the graft YS. The cytospin preparations of EGFP+
Fig. 1. Experimental strategy. To generate the yolk sac (YS)–YS chimeras, C57BL/6 Ly-5.1 or EGFP-transgenic mouse embryos at 8.25 dpc (1–5 somite pair stage),
before the establishment of circulation between the YS and the embryo proper, were separated into two pieces, the YS and the embryo proper (A). The C57BL/6 Ly-5.2
mouse embryos at 8.25 dpc were used for the host (B). A small hole (black circle) was made on the lateral side of the host YS with forceps (black arrowhead in panel
B). The host embryo was engrafted with the whole donor YS (white arrowhead) into the small hole (black circle) of the host YS (C). YS–YS chimeras were cultured
for 66 h in the whole mouse embryo culture system. After culture, YS–YS chimeras developed (D), and the donor YS looked like a projection from the host YS (white
arrowhead in panels D–F). When the YS was opened, embryo development was evident (E). Under higher magnification of the donor YS, obvious blood flow was
seen in the donor YS accompanying the heart beat of the host (F).
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derived cells in circulation contained mostly erythroid cells,
some myeloid cells and a few blastic cells, as determined mor-
phologically (Fig. 3B). Furthermore, cells were isolated from the
AGM region of the cultured YS–YS chimeras after the removal
of the blood cells and were analyzed by flow cytometry. In
addition, the AGM region contained a small number of EGFP+
graft YS-derived cells (0.54±0.04% (n=3)) (Fig. 3C). Thus, in
the YS–YS chimeras, the graft YS-derived cells were released
into the circulation of the host, and a few reached and remained
in the AGM region.
Generation of B cells derived from the graft YS
To investigate the definitive hematopoietic potential of the
engrafted YS, we focused on the B cell lineage and tried togenerate B cells from tissues of the cultured chimeric embryos.
B cell differentiation was assessed using a co-culture system
with OP9 stromal cells (Nakano et al., 1994; Nishikawa et al.,
1998). The C57BL/6 Ly-5.2 mouse embryo proper and its YS
was disaggregated with dispase and co-cultured separately with
OP9 stromal cells in the presence of SCF and interleukin (IL)-7.
The cells of each tissue from one embryo equivalent were
individually cultured in each well. After 12 to 14 days of
culture, the expression of surface markers for B cells, CD19 and
B220 was analyzed by flow cytometry. Six samples of each
tissue were examined. None of the six samples of YS tissue at
8.25 dpc generated B cells (0%), whereas one of the six samples
of embryonic proper at the same stage generated CD19+B220+
B cells (17%) (Table 2). In the embryos cultured for 66 h from
8.25 dpc, B cell potential was detected both in the YS and the
AGM region; however, the AGM region generated B cells more
Fig. 2. YS–YS chimera with donor YS from EGFP-transgenic mouse embryos. EGFP-expressing F1 embryos whose fathers were EGFP-transgenic mice and whose
mothers were C57BL/6 Ly-5.2 mice with no expression of EGFP were used for the donor YS. YS–YS chimeras were shown after culture under the regular
stereomicroscope (A) and under the fluorescence stereomicroscope (B), respectively. The arrowhead shows the graft YS. Green cells were dispersed from the donor YS
into the host body and moved through the bloodstream in synch with the host heart beat. The AGM region was isolated from the cultured YS–YS chimera (A and B)
without removing the blood and is shown under the regular stereomicroscope (C) and under the fluorescence stereomicroscope (D), respectively. In addition, green
cells were observed in the AGM region.
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We further examined B cell generation from the AGM region of
YS–YS chimeras.
The embryos of Ly-5.1 and EGFP-transgenic mice were used
as donors. The cells of the AGM region of the cultured YS–YS
chimeric embryos with vascularized grafts were co-cultured
with OP9 stromal cells. Five YS–YS chimeras, whose grafts
were from C57BL/6 Ly-5.1 mice and whose AGM regions
generated graft-derived CD19+ B cells, were obtained. Further-
more, in two of the five YS–YS chimeras, some of the CD19+ B
cells expressed CD45.1 (0.6% and 1.1%, respectively), meaning
that they were derived from the C57BL/6 Ly-5.1 donor YS.
To negate the possibility that the CD45.1+ B cells originated
through contamination with blood from the mother, we analyzed
YS–YS chimeras engrafted with YS of EGFP-expressing F1
embryos whose father was EGFP-transgenic mouse and mother
was C57BL/6 Ly-5.2 mouse without EGFP expression. In two of
three YS–YS chimeras, some CD19+ B cells expressed EGFP
(1.7% and 0.49%, respectively) derived from EGFP-expressing
donor YS, which confirms that donor YS-derived cells in the
AGM region generated B cells in the co-culture (Fig. 4). Takentogether with the results of the C57BL/6 Ly-5.1 donor YS, in
four of eight YS–YS chimeras, donor YS-derived CD19+ B cells
were detected (1.0.±0.6% (n=4)).
Furthermore, we investigated the HSC potential. When the
cells from cultured chimeric embryos were transplanted into
irradiated adult recipients, no reconstitution was observed. Even
when five AGM regions from cultured embryos were
transplanted, they could not reconstitute the adult recipients.
These results indicate that a definite number of the cells with B
cell potential were obtained from the early YS before the
establishment of circulation between the YS and the embryo
proper, although the frequency of this is low, and that the major
source of definitive hematopoiesis resides in the intra-
embryonic P-Sp/AGM region.
Discussion
Advantage of whole embryo culture in chimeric mouse embryos
When other investigators aimed to clarify the origin of defi-
nitive lymphohematopoiesis in the YS or the intra-embryonic P-
Fig. 3. The contribution of the graft YS in YS–YS chimeras. Peripheral blood from YS–YS chimeras engrafted with YS from EGFP-transgenic mice was analyzed by
flow cytometry (A). The chimeric blood contained EGFP+ cells derived from the graft YS, and the graft-derived cells comprised 12.7% of the cells. The cytospin
preparations of the EGFP+ cells sorted from the blood cells showed that most of the graft YS-derived cells in the circulation were erythroid cells and that some myeloid
cells and a few blastic cells were present (original magnification is 400×) (B). The cells isolated from the AGM region, from which blood was removed, in cultured
chimeras were analyzed (C). The AGM region contained EGFP-positive, graft YS-derived cells, which comprised 0.54% of the cells.
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circulation possibly causing an intercross of cells between the
YS and the embryo proper. Thus, we needed, as had been done in
birds and amphibians, to make chimeric embryos in which YS
tissues were engrafted on recipient embryos at the same stage
before the establishment of circulation. In mammals, however,
such experiments are difficult because of the in utero inaccess-
ibility of the developing embryos. To overcome this problem, we
used the whole mouse embryo culture system. When YS–YS
chimeras in which the YS of 8.25 dpc donor embryos were
engrafted on the YS of 8.25 dpc recipients and cultured for 66 h,
approximately 60% (147/248) of them developed, and 71.4%
(105/147) of these had blood vessel connections between theTable 2
B cell generation of various tissues of mouse embryos
Embryo Tissue No. of embryo
analyzed
No. of embryo which
generated B cells
8.25 dpc embryo YS 6 0 (0%)
Embryo proper 6 1 (17%)
Cultured embryoa YS 14 3 (21%)
AGM region 17 9 (53%)
Remnant 8 0 (0%)
The cells from 8.25 dpc embryos or cultured embryos were co-cultured with
OP9 stromal cells. B cell markers (B220 and CD19) were analyzed by flow
cytometry after 12–14 days of co-culture in the presence of SCF and IL-7.
a Developed embryos cultured for 66 h from 8.25 dpc in whole embryo
culture system were analyzed.graft YS and the host. Thus, using these chimeric embryos, we
could follow the in vivo fate of the YS-derived cells.
However, there are some limitations and disadvantage. First,
a higher skill level is required for embryonic manipulation of
mice compared with avian and amphibian experiments. In one
experiment, we could obtain only one to three chimeric embryos
because of time and technical limitations. Although we attemp-
ted flow cytometry to study surface markers on YS-derived
EGFP-expressing cells, we failed to obtain substantial numbers
of cells to draw a clear dot plot. Instead, we stained the sorted
EGFP-expressing cells to characterize them. Second, the culture
period was limited, for example, at most 72 h maximum without
micromanipulation from the stages before closure of the neural
tube (Osumi-Yamashita et al., 1997). However, with adequate
technique and aim, we can follow developmental events during
the culture period. Therefore, our system would provide a new
way to analyze early embryonic hematopoiesis in mammals.
The contribution of YS to definitive hematopoiesis
Previously, we showed that both the YS and the embryo
proper, at the stage before circulation of these two tissues is
established, could produce cells capable of differentiating into
definitive HSCs when co-cultured with stromal cells derived
from the AGM region at 10.5 dpc (Matsuoka et al., 2001). Based
on this, we hypothesized that definitive hematopoietic progeni-
tors generated in the YS would migrate to the AGM region
through the bloodstream and acquire the potential to contribute
Fig. 4. Generation of B cells in the AGM region of cultured YS–YS chimera. Cells isolated from the AGM region of various cultured embryos were co-cultured with
OP9 stromal cells for B cell generation, and the expression of EGFP and CD19 was analyzed by flow cytometry. Isotype control (A). Sample from the AGM region of
cultured C57BL/6 Ly-5.2 mouse embryo for the negative control to EGFP (B). Sample from the AGM region of a cultured EGFP-transgenic mouse embryo for the
positive control (C). Sample from the AGM region of cultured YS–YS chimeric embryo (D). Sample from the AGM region of another cultured YS–YS chimeric
embryo (E).
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generated YS–YS chimeric mouse embryos at 8.25 dpc and
incubated them in the whole embryo culture system. Because we
could not efficiently induce T cells and detect HSCs from non-
chimeric cultured embryos by fetal thymic organ culture (FTOC)
assay and adult reconstitution assay, respectively, we focused on
B cell generation. Concerning the FTOC assay, we repeated this
assay with cells of the AGM region from non-chimeric cultured
embryos more than ten times; however, we could not obtain T
cell potential. Concerning the reconstitution assay, we injected
the cells of two to five embryo equivalents from non-chimeric
cultured embryos into adult irradiated recipients, but we could
not obtain HSC potential. Although it is important to know
whether YS-derived cells have the potential of becoming T cells
and HSCs, it will be difficult to perform further experiments
concerning Tcells and HSCs using our system, and some genetic
approaches will be necessary in the future.
We showed that YS-derived cells were released into the
embryonic circulation, with some of them reaching and
remaining in the AGM region, and that the AGM region
generated B cells, with some derived from the YS graft, in the
co-culture with OP9 stromal cells. These results indicate that the
cells with B cell potential exist in the early YS, migrate to the
AGM region after the establishment of the circulation between
YS and the embryo proper and generate B cell progenitors in the
AGM region, which may not be the only generation site. We
cannot deny the effect of circulating YS-derived cells. However,
the site that could produce B cells efficiently was the AGMregion in cultured embryos. If the B cells from the AGM region
were the result of contamination of the circulation, we could
have obtained B cell potential more frequently in the YS and in
remnants of YS–YS chimeras. It is unlikely that the B cells that
we detected were because of blood contamination.
Recently, it was reported that blood vessel communication
between the YS and the embryo proper begins at the 4–5 somite
pair stage in one-third of embryos (McGrath et al., 2003). Beta-
H1 globin gene expression showed that YS-derived erythroid
cells migrate into the embryo. Although this report showed the
erythroid cell movement within blood vessels, it remains
unclear whether embryoid blood moves in circuit in the whole
body of the embryo. In addition, there has been no
morphological observation of hematopoiesis in the intra-
embryonic region at this stage (Garcia-Porrero et al., 1995).
Taken together, these results suggest that it is unlikely that the
cells in the embryo proper migrated into the graft YS used in our
experiments. To rule out the possibility that the graft YS in our
experiments contained embryo-derived cells, we reconfirmed
the somite pair number retrospectively. In two of eight chimeras
whose AGM region generated graft YS-derived B cells, the
somite pair number of the donor YS was less than 3, meaning
that YS before the establishment of blood vessel communica-
tion certainly contained B cell potential.
Thus, YS contributed to definitive lymphohematopoiesis,
although the contribution was not very significant in the present
study. If the graft YS contributed to hematopoiesis at a rate of
100%, the percentage of graft-derived B cells would be 7.9%.
60 D. Sugiyama et al. / Developmental Biology 301 (2007) 53–61This small contribution may accurately reflect the in vivo
situation similar to a previous study (Weissman et al., 1977). In
addition, such a small contribution of YS to lymphohematopoi-
esis was reported in amphibians (Bechtold et al., 1992). It has
been reported that unlike the embryo the YS contain both B and
T cell potential in vitro and in vivo before the establishment of
circulation (Palacios and Imhof, 1993). Their cell lines and
culture conditions might be extremely efficient and specific for
inducing definitive lymphohematopoietic potential from the
YS. It is of interest to compare the characteristics of their
FLS4.1 cell line derived from fetal liver and the OP9 cell line
used in the present study.
In four of eight YS–YS chimeras, donor YS-derived CD19+
B cells were not detected. This suggests several possibilities: (1)
the culture period was not sufficiently long to support the cells,
which would have B cell potential. (2) Tail degeneration had a
negative influence on AGM formation, which was expected to
support the B cell potential. (3) It might be a rare event in situ
that the YS contribute to B cell generation. (4) The direction of
anastomosis between the graft YS and the host YS might be
considered influential. In any case, the present results show the
presence of a substantial number of YS-derived B cells in the
mouse embryo and may explain the controversy in previous
reports on the role of the YS in definitive lymphohematopoiesis.
B cell potential in the early YS
It is of interest what type of cells in the early YSmigrate to the
AGM region and acquire the potential to produce B cells during
co-culture with OP9 stromal cells in the presence of SCF and
IL-7. One possibility is that they are progenitors already
committed to the B cell lineage. However, this possibility is
unlikely because 8.25 dpc YS did not generate B cells in co-
culture. Another possibility is that they are HSCs in the early YS;
however, this is unlikely because 8.0 dpc YS cells could not
reconstitute definitive hematopoiesis in adult recipients without
an organ culture step, although the early YS may contain HSCs
capable of repopulating in the neonatal fetal liver. Alternatively,
more immature cells such as hemogenic endothelial cells or
residual mesodermal cells may migrate through the circulation.
In the case of third possibility, the question is whether the
immature cells are the same cells that produce primitive
hematopoiesis or definitive erythropoiesis in YS blood islands
(Palis and Yoder, 2001). It is reported that common precursors
for primitive erythropoiesis and definitive hematopoiesis were
detected by embryoid body formation from mouse embryonic
stem (ES) cells (Kennedy et al., 1997). In addition, in Xenopus,
reciprocal grafts between ventral blood islands, from which
primitive erythrocytes were originally derived, and the dorsal
lateral plate, from which definitive hematopoietic cells were
originally derived, showed that both regions are bipotential with
respect to primitive and definitive hematopoiesis, indicating that
their fates are influenced by adjacent microenvironments
(Turpen et al., 1997). These reports suggest that precursors for
primitive hematopoiesis in the YS are capable of generating
definitive hematopoiesis when placed in the AGM region. It will
be necessary to further investigate the nature of the YS cells.Spatial and temporal regulation of hematopoietic cell
development
It was reported that the YS at 9.5 dpc contains HSCs that can
reconstitute neonatal recipients (neonatal HSCs), whereas the
cells at 9.5 dpc cannot reconstitute adult recipients (adult HSCs)
(Medvinsky and Dzierzak, 1996; Yoder et al., 1997). This
suggests that neonatal HSCs require some special microenvir-
onment to become fully functional adult HSCs. In the present
study, we showed that the YS that originally lacked the
lymphohematopoietic potential acquired B cell potential during
the whole embryo culture process. This suggests that hemato-
poietic cell development is regulated by the three-dimensional
microenvironment composed of cell–cell contacts, paracrine
factors and physical forces, such as other organs. Clarifying the
spatial and temporal regulatory mechanisms of hematopoietic
cell development will lead to the establishment of adult HSC
generation from ES cells, which is expected to have a clinical
application in the near future.
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